SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-014416
Filing Date
2023-08-10
Accepted
2023-08-10 08:21:56
Documents
69
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mgtx-20230630x10q.htm   iXBRL 10-Q 2077014
2 EX-10.3 mgtx-20230630xex10d3.htm EX-10.3 24830
3 EX-10.4 mgtx-20230630xex10d4.htm EX-10.4 22326
4 EX-31.1 mgtx-20230630xex31d1.htm EX-31.1 11371
5 EX-31.2 mgtx-20230630xex31d2.htm EX-31.2 11321
6 EX-32.1 mgtx-20230630xex32d1.htm EX-32.1 6762
7 EX-32.2 mgtx-20230630xex32d2.htm EX-32.2 6770
  Complete submission text file 0001558370-23-014416.txt   7647301

Data Files

Seq Description Document Type Size
8 EX-101.SCH mgtx-20230630.xsd EX-101.SCH 52822
9 EX-101.CAL mgtx-20230630_cal.xml EX-101.CAL 49802
10 EX-101.DEF mgtx-20230630_def.xml EX-101.DEF 197489
11 EX-101.LAB mgtx-20230630_lab.xml EX-101.LAB 394453
12 EX-101.PRE mgtx-20230630_pre.xml EX-101.PRE 342114
63 EXTRACTED XBRL INSTANCE DOCUMENT mgtx-20230630x10q_htm.xml XML 1249813
Mailing Address 450 EAST 29TH STREET 15TH FLOOR NEW YORK NY 10016
Business Address 450 EAST 29TH STREET 15TH FLOOR NEW YORK NY 10016 6464902965
MeiraGTx Holdings plc (Filer) CIK: 0001735438 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38520 | Film No.: 231157314
SIC: 2836 Biological Products, (No Diagnostic Substances)